SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569393
Filing Date
2016-04-29
Accepted
2016-04-29 16:23:11
Documents
5
Period of Report
2016-06-24
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d187287ddef14a.htm DEF 14A 682172
2 GRAPHIC g187287g71o10.jpg GRAPHIC 20657
3 GRAPHIC g187287g92z65.jpg GRAPHIC 7243
4 GRAPHIC g187287img1.jpg GRAPHIC 131307
5 GRAPHIC g187287img2.jpg GRAPHIC 79735
  Complete submission text file 0001193125-16-569393.txt   1006149
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32979 | Film No.: 161606937
SIC: 2834 Pharmaceutical Preparations